GovChime
Notice ID: a63ab723a93d4ac5952e6b64222262abSolicitation

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
5:00 PM EST
Posted
October 26, 2026
Notice type
Solicitation
Set-aside
No Set aside used
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Place of performance
Washington, District of Columbia, 20024
PSC
AN12: R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75A50126R00001_RFP_NPIVS_27
Notice ID
a63ab723a93d4ac5952e6b64222262ab

Description

BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods.

Mandatory Qualification Requirements:

To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by:

1. Holding a U.S. influenza vaccine license; or

2. Have developed an influenza vaccine as evidenced by:

                                 a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine

Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Documents

Files (27)

  • 24_75A50126R00001_RFP_0002 SF_30..pdf

    184 KBAdded in Solicitation version 7Posted
    Download
  • 23_75A50126R00001_RFP_0002 Att. 21 BARDA Responses to Contractor Question No's 1-10.pdf

    134 KBAdded in Solicitation version 7Posted
    Download
  • 01-75A50126R00001_RFP_Final.pdf

    1.2 MBAdded in Solicitation version 6Posted
    Download
  • 22_75A50126R00001_RFP_0001 Att. 20 BARDA Responses to Contractor Question No's 1-7.pdf

    96 KBAdded in Solicitation version 6Posted
    Download
  • 21_75A50126R00001_RFP_0001_RFP File 3 of 3.pdf

    322 KBAdded in Solicitation version 6Posted
    Download
  • 21_75A50126R00001_RFP_0001_RFP File 2 of 3.pdf

    405 KBAdded in Solicitation version 6Posted
    Download
  • 21_75A50126R00001_RFP_0001_RFP File 1 of 3.pdf

    377 KBAdded in Solicitation version 6Posted
    Download
  • 20_75A50126R00001_RFP_0001.SF30.pdf

    188 KBAdded in Solicitation version 6Posted
    Download
  • 15-75A50126R00001_RFP Att 15 Contractor Questions.xlsx

    20 KBAdded in Solicitation version 2Posted
    Download
  • 19_75A50126R0001_RFP Att 19 Surge Manufacturing and Supply Chain Readiness Assessment.pdf

    41 KBAdded in Solicitation version 2Posted
    Download
  • 18-75A50126R00001_RFP Att 18 BCP SCP Continuity Plans.pdf

    75 KBAdded in Solicitation version 2Posted
    Download
  • 17-75A50126R00001_RFP Att 17 Manufacturing Plan.pdf

    60 KBAdded in Solicitation version 2Posted
    Download
  • 16-75A50126R00001_RFP Att 16 Bill of Materials (BOM) Template.xlsx

    93 KBAdded in Solicitation version 2Posted
    Download
  • 14-75A50126R00001_RFP Att 14 Past Perfomance Questionnaire Template.docx

    184 KBAdded in Solicitation version 2Posted
    Download
  • 13-75A50126R00001_RFP Att 13 Risk Mitigation Plan Matrix Template.docx

    31 KBAdded in Solicitation version 2Posted
    Download
  • 12-75A50126R00001_RFP Att 12 HHS Subcontracting Plan Template.docx

    80 KBAdded in Solicitation version 2Posted
    Download
  • 11-75A50126R00001_RFP Att 11 SF LLL Disclosure of Lobbying Activities Form Instructions.pdf

    312 KBAdded in Solicitation version 2Posted
    Download
  • 10-75A50126R00001_RFP Att 10 SF LLL Disclosure of Lobbying Activities Form.pdf

    89 KBAdded in Solicitation version 2Posted
    Download
  • 09-75A50126R00001_RFP Att 9 ACH Vendor Misc Payment Enrollment Form.docx

    61 KBAdded in Solicitation version 2Posted
    Download
  • 08-75A50126R00001_ RFP Att 8 Summary of Related Activities.docx

    36 KBAdded in Solicitation version 2Posted
    Download
  • 07-75A50126R00001_RFP Att 7 Breakdown of Proposed Costs.xlsx

    23 KBAdded in Solicitation version 2Posted
    Download
  • 06-75A50126R00001_RFP Att 5 BARDA Dose Tracker Template.xlsx

    115 KBAdded in Solicitation version 2Posted
    Download
  • 05-75A50126R00001_RFP Att 4 Agent Request Form.docx

    40 KBAdded in Solicitation version 2Posted
    Download
  • 04-75A50126R00001_RFP Att 3 Vendor Production Facilities.xlsx

    25 KBAdded in Solicitation version 2Posted
    Download
  • 03-75A0126R00001_RFP Att 2 ASPR Security Requirements.pdf

    118 KBAdded in Solicitation version 2Posted
    Download
  • 02-75A50126R00001_RFP Att 1 Prod Handling Guidance Don Nat.pdf

    62 KBAdded in Solicitation version 2Posted
    Download
  • 75A50126R00001 NPIVS RFP_PresolNotice.pdf

    160 KBAdded in Presolicitation version 7Posted
    Download

Lifecycle

  1. 4
    Version 4PresolicitationArchived

    Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

    Notice 7f2d0909120749a39c61c64ff933f1a6 on SAM.gov

  2. 2
    Version 2Solicitation

    Type changed from Presolicitation to Solicitation

    Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

    Notice 2e4d29dade93498da98c07dacb2374e6 on SAM.gov

  3. 3
    Version 3Solicitation

    Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

    Notice 38ae60ea2cb04f5d8d14713946892925 on SAM.gov

  4. 6
    Version 6Solicitation

    Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

    Notice d547606225884278817f5008d9a07e99 on SAM.gov

  5. 7
    Version 7SolicitationCurrent

    Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

    Notice a63ab723a93d4ac5952e6b64222262ab on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

75A50126R00001_RFP_NPIVS_27

Archive Date

Dec 5, 2026

Office Address

WASHINGTON, DC, 20515